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In October 2016, a severe infection with swine influ-
enza A(H1N1) virus of the Eurasian avian lineage 
occurred in a child with a previous history of eczema 
in the Netherlands, following contact to pigs. The 
patient’s condition deteriorated rapidly and required 
life support through extracorporeal membrane oxy-
genation. After start of oseltamivir treatment and 
removal of mucus plugs, the patient fully recovered. 
Monitoring of more than 80 close unprotected con-
tacts revealed no secondary cases.
We here report a patient with severe acute respira-
tory infection as a result of swine influenza virus (SIV) 
infection in the Netherlands.
Case description
A school-aged patient with a previous history of mild 
eczema developed a respiratory tract infection in 
October 2016, a couple of days after visiting a pig farm. 
The child had entered the pigsty but had not been in 
direct contact with pigs. Despite early prescription of 
antibiotics by the general practitioner the child’s clini-
cal situation rapidly deteriorated. Within three days 
after onset of disease the child was transferred to a 
paediatric intensive care unit (PICU) for non-invasive 
ventilation support and intensive monitoring. Despite 
these efforts, the patient deteriorated further and 
was intubated in order to start mechanical ventila-
tion. Bronchoscopy following intubation revealed large 
amounts of highly viscous mucus in the airways. Efforts 
to remove this mucus failed to improve ventilation. 
Mechanical ventilation became increasingly complex 
and it was decided to initiate veno-venous extracor-
poreal membrane oxygenation (ECMO) and to transfer 
to a quaternary PICU. Due to ECMO, blood oxygenation 
was secured and extensive bronchoscopy could be per-
formed, during which topical DNAse (Dornase alpha, 
Pulmozyme, Roche) was instilled to decrease viscos-
ity and facilitate removal of obstructing mucus plugs. 
On the following day, bronchoscopy was repeated and 
additional mucus was removed.
In the days following these procedures, the patient 
improved rapidly. ECMO was discontinued five days 
after start and the patient could be extubated. For 
the entire duration of hospitalisation, the patient had 
received broad-spectrum antibiotics, although all bac-
terial cultures remained negative. Throat swabs had 
been collected at initial admission and tested posi-
tive for influenza A virus, of which the quaternary PICU 
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was informed on the day after the patient transfer. 
Oseltamivir treatment (60 mg twice daily) was started 
hours after initiation of ECMO and transport. It was con-
tinued for a total of 7 days when a nasal swab tested 
negative for influenza virus. At the time of submission 
of this report, the child was recovering well.
Virological results
The initial diagnostic routine was limited to testing for 
the influenza A virus matrix gene, without subtyping. 
In view of the severe course of illness, the child was 
resampled for repeated testing including typing of the 
haemagglutinin (HA) gene by quantitative real-time 
PCR for H1 (seasonal and pdm2009), H3, H5, H7 and 
H9. All typing PCRs were negative.
We determined the full virus genome sequences of a 
cell culture isolate derived from a respiratory tract 
sample using Illumina MiSeq. All gene segments 
(GenBank accession numbers KY250316-KY250323) 
were 97–98% and 98–100% identical at, respectively, 
nucleotide and amino acid level to publicly available 
SIV sequences from the Netherlands (GISAID accession 
numbers EPI639351, EPI639914, EPI639917, EPI639930, 
EPI640657, EPI640912, EPI641210, EPI641215). The 
gene segments were all of the Eurasian avian A(H1N1) 
SIV lineage that has been circulating in pigs since 1979 
[1]. Pigs at the farm visited by the patient tested posi-
tive for the same SIV (curation of full genome sequence 
data is in progress). The virus isolate from the patient, 
A/Netherlands/3315/2016, was sensitive to oseltami-
vir and zanamivir by NA-star neuraminidase inhibi-
tor resistance detection assay (Applied Biosystems, 
Nieuwerkerk aan den IJssel, The Netherlands).
Public health measures
Zoonotic influenza is a notifiable disease in the 
Netherlands. Following confirmation of the zoonotic 
SIV infection, the national and relevant municipal pub-
lic health authorities were notified and a teleconfer-
ence was organised to decide on measures. The risk 
for human-to-human transmission was considered very 
low, given the enzootic presence of swine influenza 
viruses and the fact that zoonotic infections are sel-
dom diagnosed.
In order to detect human-to-human transmission at an 
early stage, it was decided to contact all individuals 
that had been in close direct contact with the patient 
without wearing personal protective equipment, and 
monitor them for symptoms of possible SIV infection 
(cough, fever or conjunctivitis) for 10 days after expo-
sure. In total, more than 80 contacts were monitored. 
These included the patient’s family members living in 
the same household, persons living and working on 
the pig farm, and healthcare workers who cared for 
the patient without wearing personal protective equip-
ment (i.e. before the influenza diagnosis). Six contacts 
developed mild respiratory symptoms including cough, 
coryza and conjunctivitis during the monitoring period 
but all tested negative for influenza A virus.
According to the international health regulations, this 
case has been notified to the European Union Member 
States and the European Centre for Disease Prevention 
and Control (ECDC) through the Early Warning and 
Response System (EWRS) and to the World Health 
Organization (WHO).
Discussion
Incidental cases of human infection with SIV have 
been reported worldwide since the late 1950s. Most of 
these were in individuals exposed to pigs. Apart from 
one isolated incident in military barracks in the United 
States (US), sustained and efficient human- to- human 
transmission had not been documented before 2009, 
when an influenza virus of swine origin triggered the 
first influenza pandemic of the 21st century. Indeed it 
is speculated that pigs may serve as a mixing vessel for 
the development of a pandemic influenza strain [2-5]. 
In addition, SIV infections account for roughly one third 
of all laboratory-confirmed zoonotic influenza events 
reported in the scientific literature [3]. This may be a 
gross underestimation of the actual number as there 
are no typical signs and symptoms that distinguish SIV 
infections in humans from those caused by seasonal 
influenza viruses [4]. Indeed several sero-epidemiolog-
ical studies suggest that SIV infection in people with 
occupational swine exposure is common [6-8]. In the 
US, there is a routine surveillance for swine influenza 
in pigs, and 400 patients with a swine influenza infec-
tion have been reported through this system since 
2005 [9]. Our case shows that careful assessment of 
airway disease in individuals exposed to pigs contin-
ues to be important, especially considering the impor-
tance of starting of antiviral treatment early.
Conclusion
We here describe that transmission of SIV to humans, 
though rare, can occur and cause severe disease requir-
ing life support through ECMO. Monitoring of people 
in direct contact and not wearing personal protective 
equipment revealed no secondary cases.
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